FASN-IN-1

• UNSPSC Description:

  FASN-IN-1 is a fatty acid synthase (FASN) inhibitor extracted from patent WO2015134790A1, compound 56[1].

• Target Antigen:

  Fatty Acid Synthase (FASN)

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/fasn-in-1.html

• Purity:

  99.90

• Solubility:

  DMSO : 100 mg/mL (ultrasonic)

• Smiles:

  CC[C@H](C)C(NC1=NC(C2=CC=C(S(=O)(N(CC)CC)=O)C=C2)=CS1)=O

• Molecular Weight:

  395.54

• References & Citations:

  [1]Nicholas D.P. Cosford, et al. Small molecule fatty acid synthase inhibitors. WO2015134790A1.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Clinical Information:

  No Development Reported

• CAS Number:

  1808260-84-5